Interestingly, tryptophan 2,3-dioxygenase (TDO2) serves as a common immune metabolism checkpoint for HCC and ICC, which is consistent with the “cofactor metabolic process” previously identified as a common metabolic process between HCC and ICC. This evidence concerns the gene TDO2 and intrahepatic cholangiocarcinoma.